Pedro Otavio de Campos Lima in research grants and scholarships supported by FAPESP.
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
The immune system has the ability to recognize damage-associated molecular patterns (DAMPs) generated by tumor growth, which can lead to its elimination or continued inflammation. The initial innate immune response sets the stage for a specific adaptive immune reaction that is equipped to eradicate the neoplastic lesion, and often happens long before the disease becomes clinically detecta…
There has been considerable progress in the approach adopted for the treatment of acute lymphoblastic leukemias over the past decades partly due to the stratification of patients by risk groups. The incorporation of new tools into the therapeutic arsenal, such as rituximab and allogeneic bone marrow transplantation has also contributed to this success. However, an important group of patie…
Acute lymphoblastic leukemia (ALL) is the most common cancer in children, representing 31% of all tumors. The conventional treatment of pediatric ALL is based on chemotherapeutic protocols that have shown good results with cure rates close to 80-90%. Despite this, 10-20% of children fail to respond to first-line therapy as well as have disease recurrence. The immunotherapy with geneticall…
| 1 / 1 | Ongoing research grants |
| 1 / 1 | Completed research grants |
| 1 / 1 | Completed scholarships in Brazil |
| 3 / 3 | All research grants and scholarships |
| Associated processes | |
CV Lattes
ORCID